However, while randomized clinical trials proved that anti-inflammatory and pro-resolving corticosteroids can improve survival in severe COVID-19 [64], dexamethasone therapy did not affect plasma chemerin levels [62]. This evidence concerns the gene RARRES2 and COVID-19.